Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Anticuerpos Primarios

Anti-Human SLC22A5 Polyclonal Antibody (HF955014)

Precio(USD): --
Especificación:
  • 50ug
  • 100ug
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHF955014
Descripción
Anti-Human SLC22A5 Polyclonal Antibody (HF955014) is a rabbit polyclonal antibody detecting SLC22A5 in ELISA, IHC, WB. Suitable for Human.
Highlights
  • ●Affinity Purified — Minimal background and high purity for reliable results.
  • ●Multi-Application — Validated across multiple applications.
Reactividad de especiesHuman
AplicacionesELISA, IHC, WB
Especie huéspedRabbit
ClonalidadPolyclonal
IsotipoIgG
Inmunógeno E. coli - derived recombinant Human SLC22A5 (Thr45-Lys141).
Objetivo SLC22A5, Organic cation/carnitine transporter 2, High-affinity sodium-dependent carnitine cotransporter, OCTN2, Solute carrier family 22 member 5
Purificación Purified by antigen affinity column.
Número de acceso O76082
Forma Liquid
Buffer de almacenamiento 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto
Aplicación Dilución
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo

Organic cation/carnitine transporter 2 (SLC22A5) is a ~62 kDa protein. Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Relative uptake activity ratio of carnitine to TEA is 11.3.

1. Wu, X. et al. (1999) The Journal of pharmacology and experimental therapeutics 290, 1482-92. PMID: 10454528
2. Ohashi, R. et al. (1999) The Journal of pharmacology and experimental therapeutics 291, 778-84. PMID: 10525100
3. Wagner, CA. et al. (2000) American journal of physiology. Renal physiology 279, F584-91. PMID: 10966938
4. Maekawa, S. et al. (2007) Biochimica et biophysica acta 1773, 1000-6. PMID: 17509700
5. Fujiya, M. et al. (2011) Inflammatory bowel diseases 17, 907-16. PMID: 20722056
6. Yee, SW. et al. (2020) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34, 15734-15752. PMID: 33124720
7. Fujiya, M. et al. (2007) Cell host & microbe 1, 299-308. PMID: 18005709
Nota For research use only.
Imágenes
Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores